 CMV esophagitis
Definition Alternative Names Causes, incidence, and risk factors Symptoms Signs and tests Treatment Expectations (prognosis) Complications Calling your health care provider Prevention References DefinitionCytomegalovirus (CMV) esophagitis is a viral infection of the esophagus, the muscular tube through which food travels from the mouth to the stomach. See also: Alternative NamesCytomegalovirus esophagitis Causes, incidence, and risk factorsCMV esophagitis is caused by the cytomegalovirus (CMV). The condition is often a sign of a weakened immune system. The following conditions raise your risk for CMV infections: SymptomsSymptoms include: - Difficult and painful swallowing
- Low-grade fever
- Mouth sores (oral lesions)
Signs and testsTreatmentTreatment involves antiviral medications that are given through a vein (intravenously), such as ganciclovir or foscarnet. In some cases, patients are given an antiviral medicine called valganciclovir, which is taken by mouth. Some people with this condition also need pain medicine. Many people who are treated for an episode of CMV esophagitis take medicine to suppress the CMV for a long time. Expectations (prognosis)Esophagitis can usually be treated effectively. The outcome depends on the immune system problem that makes the person more likely to get the infection. Complications- Infection at other sites
- Holes in your esophagus (perforations)
- Recurrent infection
Calling your health care providerCall your health care provider if you develop symptoms of CMV esophagitis, especially if you have a suppressed immune system. PreventionPreventing AIDS can help avoid opportunistic infections, such as those caused by CMV. Opportunistic infections are caused by organisms that do not usually lead to disease, but that take advantage of a damaged immune system. People with AIDS who are effectively treated with antiretroviral therapy are much less likely to get CMV infection. ReferencesDrew WL. Cytomegalovirus. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 399.
Review Date: 8/28/2009
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
|